Quarterly Result14 Aug 2026, 05:38 pm
Norris Medicines Declares Un-Audited Q1 FY27 Results
AI Summary
Norris Medicines Limited announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors also approved the appointment of Mr. Vimal Dhirendra Shah as Managing Director for a term of three years, effective September 1, 2026, subject to shareholder approval. The company is arranging to publish the financial results in newspapers as per SEBI regulations. The board meeting commenced at 3:00 PM and concluded at 4:00 PM.
Key Highlights
- Norris Medicines declared un-audited financial results for Q1 FY27.
- Mr. Vimal Dhirendra Shah appointed as Managing Director.
- Appointment is for a term of three years effective Sept 1, 2026.
- Appointment is subject to shareholder approval.
- Results to be published in newspapers as per SEBI regulations.
Price Impact
More from NORRIS